Malin Corporation | MLC - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.01M 153K 2026-03
ALKERMES USD 501K 66.98M 2026-06
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Eurofins Scientific SE EUR 302M 108.3M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Lonza CHF 426M 119M 2025-06
Malin Corporation EUR -1.1M 2.2M 2023-12
Moderna USD -1.34B 517M 2026-03
Organon & Co USD 108M 38M 2026-06
Ovoca Bio EUR 4.42M 5.19M 2025-12
Revvity USD 51.82M 11.1M 2026-06
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Viatris USD -118.8M 295.2M 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03